News
.png)
My focus is on building a master plan for addressing health care for rare and orphan diseases patients in India says Prof Vijay Chandru
Prof Vijay Chandru, one of the speakers in the Genetics and Medicine panel at LMSAI Annual Cambridge Symposium Science and Technology
Its time to become bio manufacturing hub of the world Deepanwita Chattopadhyay CEO IKP Knowledge Park
Deepanwita spoke to indianexpress.com on the challenges faced by life sciences startups, the need for patient capital in deeptech research, and IKP’s mentoring of life sciences startups among other things.
ABLE member HiMedia Revolutionizes Nucleic Acid Extraction Across Industries with Automated Systems
HiMedia, a leader in laboratory solutions, is spearheading a revolution in nucleic acid extraction across various industries through its Molecular Biology & Virology Division (HiGenoMB).
ABLE member Syngene International Reports FY24 Results Revenue Up 9% PAT Rises 12%
Syngene International has unveiled its full-year and fourth quarter results for the fiscal year 2024. The company reported a nine percent increase in revenue from operations for the full year, reaching Rs. 3,489 crore, accompanied by a 12 percent rise in profit after tax (PAT), before exceptional items, totaling Rs. 519 crore.
Exhibit in the 'India Pavilion' at BIO 2026
